Interstitial Lung Disease (ILD) is a group of lung diseases that affects the tissues and spaces around the air sacs of the lung and may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of inflammation to protect the body and repair the damage, but in ILD, the inflammation and repair process goes awry and the tissue around the air sacs becomes scarred and thickened, a process called fibrosis. This makes it more difficult for oxygen to pass into the bloodstream and sufferers often experience shortness of breath or coughing.
We are evaluating the safety and tolerability of an experimental new drug being developed to investigate a potential treatment for people with inflammatory and degenerative diseases.
This study is currently not recruiting further participants at this time.